rawfin.tv
MaxCyte CEO Granted 600,000 Stock Options and 300,000 RSUs
MarketsstocksAI Generated

MaxCyte CEO Granted 600,000 Stock Options and 300,000 RSUs

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

MaxCyte (MXCT) CEO Masoud Maher received a substantial equity compensation package. The award includes 600,000 stock options and 300,000 restricted stock units (RSUs).

MaxCyteExecutive CompensationStock OptionsRSUsCorporate GovernanceBiotech Sector

Related Articles

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

stocks
SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

stocks
Elon Musk Explores Merger Between SpaceX and Tesla

Elon Musk Explores Merger Between SpaceX and Tesla

stocks
Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks